Helmut Butzkueven

Projects

Projects per year 2005 2027

• 14 Active
• 16 Finished

Projects per year

Search results

• Active

  The role of monocytes and P2X7 Receptor in the pathogenesis of relapsing remitting multiple sclerosis flare: a translational study.

  Monif, M. & Butzkueven, H.

  Multiple Sclerosis Research Australia

  18/03/21 → 31/12/23

  Project: Research

• The contribution of monocytes and P2X7 Receptor in Multiple Sclerosis relapse.

  Monif, M., Butzkueven, H., O'Brien, T. & Stankovich, J.

  2/03/21 → 31/12/21

  Project: Research

• Revolutionising Multiple Sclerosis Care and trials through e-health

  Butzkueven, H.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/21 → 31/12/25

  Project: Research

• Autoimmune Encephalitis - a rare and debilitating neurological illness affecting the Australian population. A study of the Australian Autoimmune Encephalitis Consortium.

  Monif, M., Butzkueven, H., Reddel, S. W., Kalincik, T., Tarlinton, D., Seneviratne, U., Kulkarni, J., Buzzard, K. & Taylor, B. V. M.

  1/06/20 → 31/05/24

  Project: Research

• Active self-monitoring to prospectively detect treatment failure and define subclinical progression trajectories in multiple sclerosis: The ACTIVE-MS Program.

  Van Der Walt, A., Butzkueven, H., Jokubaitis, V., Kolbe, S., Vogel, A. P., Stankovich, J., Butler, E., Macdonell, R. A. L. & Darby, D.

  Trish Multiple Sclerosis Research Foundation

  1/01/20 → 31/12/22

  Project: Research

• Monash-Roche Meaningful Data at Scale Collaboration for MS

  Van Der Walt, A. & Butzkueven, H.

  Hoffmann-La Roche Switzerland

  6/12/19 → 31/12/27

  Project: Research

• Collaboration on Roche Managed Primary Data Collection NIS and RWD Analytics Activities

  Butzkueven, H. & Van Der Walt, A.

  Hoffmann-La Roche Switzerland

  6/12/19 → 1/12/26

  Project: Research

• Analysis of Real-World Long-Term Effectiveness of Ocrelizumab in Primary Progressive MS Disease

  Butzkueven, H. & Hinson, E.

  11/09/19 → 30/11/23

  Project: Research

• Active Participatory Health Monitoring in people with Multiple Sclerosis to improve treatment outcomes (Active-MS)

  Butzkueven, H., Van Der Walt, A., Darby, D., Stankovich, J., Jokubaitis, V., Skibina, O., Marriott, M., Butler, E. & Gresle, M.

  Department of Health (Australia)

  1/07/19 → 30/06/21

  Project: Research

• CLADIN sub study. Effect of CLADribine on Innate Immune Response (CLADIN). MS Immunity Project.

  Monif, M., Butzkueven, H. & O'Brien, T.

  27/06/19 → 9/09/22

  Project: Research

• Improved monitoring of Multiple Sclerosis (MS) using patient-derived and MRI scan information.

  Butzkueven, H.

  6/06/19 → 27/02/23

  Project: Research

• A global prospective open access study to assess and optimize the monitoring of Multiple Sclerosis using smartphones (floodlight open study)

  Butzkueven, H. & Gresle, M.

  31/03/19 → 31/03/24

  Project: Research

• Next generation biomarkers for multiple sclerosis

  Kolbe, S., Van Der Walt, A., Butzkueven, H., Kalincik, T. & Kilpatrick, T. J.

  Biogen Australia Pty Ltd

  1/01/19 → 31/12/21

  Project: Research

• Prospective clinic and home-based serial monitoring of cognition in relapsing-remitting multiple sclerosis.

  Van Der Walt, A. & Butzkueven, H.

  13/09/18 → 13/11/22

  Project: Research

• Finished

  Pharmacogenomic prediction of treatment response in multiple sclerosis

  Van Der Walt, A., Jokubaitis, V. & Butzkueven, H.

  21/10/19 → 20/04/20

  Project: Research

• NHMRC Equipment Grant - Quanterix SIMOA HD-X Analyser

  Shultz, S., Kwan, P., Medcalf, R., O'Brien, T., Mitra, B., Coughlan, M., Jones, N., Van Der Walt, A., Butzkueven, H., Semple, B. & Hutton, E.

  Monash University – Internal Faculty Contribution, Monash University – Internal Department Contribution

  1/01/19 → 31/12/19

  Project: Research

• PrevANZ: Phase IIb Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Trial of Vitamin D3 in Patients with a First Demyelinating Event.

  Butzkueven, H.

  5/12/18 → 31/12/20

  Project: Research

• PhD Project: Altered Vitamin D responsiveness in Multiple Sclerosis Immune Cells.

  Butzkueven, H., Van Der Walt, A., Stankovich, J., Jokubaitis, V. & Monif, M.

  Roche Australia

  16/10/18 → 1/01/20

  Project: Research

• Mark Pennycook Foundation Research Donation

  Butzkueven, H.

  22/06/18 → 1/07/19

  Project: Research

• Characterizing the effects of vitamin D supplementation on immune gene expression in patients with a clinically isolated syndrome.

  Butzkueven, H., Taylor, B. V. M. & Lucas, R. M.

  1/01/18 → 31/12/19

  Project: Research

• Improving Multiple Sclerosis treatment outcomes

  Butzkueven, H.

  National Health and Medical Research Council (NHMRC) (Australia)

  1/01/18 → 31/12/19

  Project: Research

• Multiple Sclerosis Clinical Trials

  Butzkueven, H.

  1/01/15 → 31/12/20

  Project: Research

• Randomised Control Trial to determine whether nurse-initiated management improves bladder and bowel function in people with Multiple Sclerosis

  Kurczycki, L. & Butzkueven, H.

  Multiple Sclerosis Research Australia

  1/01/14 → 31/12/14

  Project: Research

• Randomised Control Trial to determine whether nurse-initiated management improves bladder and bowel function and quality of life in people with Multiple Sclerosis

  Butzkueven, H. & Kurczycki, L.

  Multiple Sclerosis Research Australia

  1/01/14 → 31/12/15

  Project: Research

• The multi-national Gilenya Pregnancy exposure registry in multiple sclerosis

  Butzkueven, H.

  1/05/13 → 31/03/17

  Project: Research

• Phase Iib Randomised double blind placebo controlled dose ranging trial of Vitamin D3 in patients with a first Demyelinating event

  Butzkueven, H.

  1/04/13 → 1/11/16

  Project: Research

• A multicentre, randomised, double blind, parallel group, placebo controlled variable treatment duration study evaluating the efficacy and safety of Piponimod (BAF312) in patients with secondary

  Butzkueven, H.

  18/02/13 → 29/05/14

  Project: Research

• Long-term, prospective, multinational prallel-cohort study monitoring safety in patients with MS newly started with fingolimod once daily or treated with another approved disease-modifying therapy

  Butzkueven, H.

  1/10/12 → 22/06/15

  Project: Research

• A multicentre open-label non-randomised parallel group clinical trial to assess the efficacy of Fingolimod in naive patients v Fingolimod in patients previously treated with interferons or glatiramer

  Butzkueven, H.

  25/06/12 → 1/12/13

  Project: Research

• A multicentre, single arm, open-label, phase IIIb study to evaluate the safety and antigenicity of Rebif (IFN-beta-1a) in subjects with relapsing forms of multiple sclerosis

  Butzkueven, H. & Gibson, P.

  1/08/05 → 25/12/07

  Project: Research